首页> 外文期刊>Pediatric dermatology >Individualized Dosing of Oral Oxybutynin for the Treatment of Primary Focal Hyperhidrosis in Children and Teenagers
【24h】

Individualized Dosing of Oral Oxybutynin for the Treatment of Primary Focal Hyperhidrosis in Children and Teenagers

机译:口服奥昔布宁个人剂量治疗儿童和青少年原发性多汗症

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Objectives: Oral anticholinergic drugs, such as oxybutynin, are often used in the treatment of hyperhidrosis, but few studies have focused on dosing strategies for children. The objective was to assess the effectiveness and safety of individualized dosing regimens of oral oxybutynin for treating primary focal hyperhidrosis ( PFH) in children and teenagers.
机译:背景/目的:口服抗胆碱能药物,例如奥昔布宁,通常用于治疗多汗症,但很少有研究关注儿童的给药策略。目的是评估口服奥昔布宁个性化给药方案治疗儿童和青少年原发性多汗症(PFH)的有效性和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号